Publications (30) Publications de ROSA MARIA IZU BELLOSO

2024

  1. Experience With Bexarotene to Treat Cutaneous T-Cell Lymphomas: A Study of the Spanish Working Group of Cutaneous Lymphomas

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 6, pp. 547-554

  2. Family Planning Concerns Among Women With Psoriasis: A Descriptive, Cross-Sectional, Multicenter Study

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 1, pp. 10-20

  3. Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice

    Experimental Dermatology, Vol. 33, Núm. 8

  4. Real-World Clinical, Psychosocial and Financial Burden of Atopic Dermatitis: Results from the Spanish Cohort of the MEASURE-AD Trial

    Actas Dermo-Sifiliograficas

  5. Tratamiento del prurigo nodular con Dupilumab: Nuestra experiencia

    Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios, Vol. 121, Núm. 1, pp. 1-9

  6. [Translated article] Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 3, pp. T237-T245

2023

  1. Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease Stage

    Actas Dermo-Sifiliograficas

  2. Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study

    Actas Dermo-Sifiliograficas

2022

  1. EORTC-QLQ-C30 and SKINDEX-29 measurement of health-related quality of life in patients with mycosis fungoides and Sézary syndrome: Real-world data in Spanish patients (MICADOS Study)

    JEADV Clinical Practice, Vol. 1, Núm. 4, pp. 438-449

  2. [Translated article] Waxy Palms and Soles in an Adolescent Girl

    Actas Dermo-Sifiliograficas, Vol. 113, Núm. 10, pp. T957-T958

2021

  1. EORTC-QLQ-C30 and SKINDEX-29 measurement of health-related quality of life in patients with mycosis fungoides and Sézary syndrome: real-world data in Spanish patients (MICADOS study)

    European Journal of Cancer, Vol. 156, pp. S29-S30

  2. Epidermolysis bullosa nevus

    Piel, Vol. 36, Núm. 1, pp. 19-21

  3. Gamificación en la docencia de dermatología

    FEM. Revista de la Fundación Educación Médica, Vol. 24, Núm. 1, pp. 54-58

2020

  1. Cost of early-stage mycosis fungoides treatments in Spain

    ClinicoEconomics and Outcomes Research, Vol. 12, pp. 91-105

  2. Merkel cell carcinoma. A retrospective observational study (1998-2018) in a University Hospital

    Medicina Cutanea Ibero-Latino-Americana, Vol. 48, Núm. 1, pp. 63-68

  3. Therapeutic and follow-up attitude of the patient diagnosed with some type of cutaneous mastocytosis

    Piel, Vol. 35, Núm. 3, pp. 184-189

2019

  1. Final Phase in the Validation of the Cross-Cultural Adaptation of the Hair-Specific Skindex-29 Questionnaire Into Spanish: Sensitivity to Change and Correlation With the 12-Item Short-Form Health Survey

    Actas Dermo-Sifiliograficas, Vol. 110, Núm. 10, pp. 819-829

  2. Optimal concentration range of ustekinumab in patients with plaque-type psoriasis

    Journal of the American Academy of Dermatology, Vol. 80, Núm. 6, pp. 1782-1784

  3. Sister Mary Joseph’s nodule. A case-series

    Medicina Cutanea Ibero-Latino-Americana, Vol. 47, Núm. 2, pp. 139-143

  4. Treatment of moderate-to-severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series

    British Journal of Dermatology